Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Channel 4 dominates 30th Annual Broadcast Awards 2025 with eight wins

London, United Kingdom, 07 February 2025 – The Broadcast Awards 2025 celebrated its 30th anniversary on Wednesday night in a star-studded ceremony at JW Marriott Grosvenor House Hotel on Park Lane, London, where Channel 4 led the night with an impressive eight wins. The event was organised by Media Business Insight (MBI) Ltd, a GlobalData […]
Read more

Barclays tech outage highlights legacy banking system risks amid rising digital competition, says GlobalData

Barclays, British multinational universal bank, faced a severe 48-hour technical outage (31 January-2 February), disrupting payments and online banking for millions of UK customers. The incident underscores the persistent vulnerabilities of legacy banking systems, despite substantial ICT investments. As digital-native challengers redefine industry standards, traditional banks must accelerate transformation or risk losing relevance in an […]
Read more

Robust corporate governance a strategic imperative for business resilience and growth, says GlobalData

Effective corporate governance is essential for sustainable business growth. As regulatory scrutiny intensifies, companies must strengthen governance frameworks, including risk management and anti-corruption measures, to ensure compliance and long-term resilience. Weak governance can undermine trust, while a well-structured approach enhances competitiveness, drives value creation, and positions businesses for sustained success, according to GlobalData, a leading […]
Read more

Alternative payments account for over half of total e-commerce payments in Australia, reveals GlobalData

Alternative payment methods such as mobile and digital wallets and buy now pay later (BNPL) solutions have reshaped Australia’s e-commerce landscape, overtaking traditional cash and card payments. With a 53% market share in 2024, these digital solutions are driving seamless transactions, fuelling online sales, and reinforcing the sector’s robust growth trajectory, reveals GlobalData, a leading […]
Read more

Top 20 global biopharma firms see 1.7% market cap growth to $3.7 billion in 2024 amid policy challenges, reveals GlobalData

The biopharmaceutical industry in 2024 experienced a mixed performance, with the aggregate market capitalization of the top 20 biopharmaceutical firms’ year-on-year increasing by 1.7% from $3.6 trillion to $3.7 trillion as on 31 December 2024, despite challenges from shifting policies and regulatory concerns. Key players like Lilly, AbbVie, and Gilead Sciences saw significant growth, while […]
Read more

Need for mission readiness to drive maintenance expenditure on in-service military platforms in Asia-Pacific in 2025, says GlobalData

The evolving nature of warfare and threat perceptions in the Asia-Pacific region has increased the demand for robust maintenance, repair, and overhaul (MRO) practices substantially. Disciplined MRO practices ensure higher operational availability rates of military platforms such as fixed-wing aircrafts, helicopters, naval vessels, and land vehicles. Against this backdrop, the cumulative maintenance cost burden of […]
Read more

AI, ESG, and cyber will be the key insurance themes in 2025, says GlobalData

The insurance industry is set to be defined by the transformative impact of artificial intelligence (AI), environmental, social, and governance (ESG), and cyber risk management in 2025. As consumers increasingly embrace AI-driven solutions and express growing interest in personal cyber coverage, insurers face both challenges and significant opportunities to innovate, personalize offerings, and integrate emerging […]
Read more

US VC funding surges 34.6% to $148.8 billion in 2024 despite decline in deal volume, reveals GlobalData

The US venture capital (VC) market demonstrated remarkable resilience in 2024, achieving a year-on-year (YoY) 34.6% surge in total funding value to $148.8 billion, despite a double-digit decline in deal volume. This impressive growth, driven by high-value investments, underscores robust investor confidence and reaffirms the US’s position as a global leader in the innovation-driven venture […]
Read more

LVMH ad strategy combines heritage and innovation to strengthen luxury brand appeal, reveals GlobalData

LVMH Moet Hennessy Louis Vuitton’s (LVMH) advertising initiatives between October and December 2024 seamlessly blend heritage with innovation. By strategically aligning with high-profile sporting events like the America’s Cup and collaborating with renowned artists, the brand aims to strengthen its luxury image. Through dynamic storytelling, celebrity endorsements, and behind-the-scenes content, the Paris-based luxury goods giant […]
Read more

South Korea bone graft and substitutes market to grow at 4% CAGR through 2033, forecasts GlobalData

The increasing prevalence of orthopaedic conditions such as osteoarthritis, osteoporosis, and trauma-related injuries is driving the need for innovative and efficient bone regeneration solutions. Against this backdrop, South Korea’s bone graft and substitutes market is set to grow at a compound annual growth rate (CAGR) of around 4% through 2033, says GlobalData, a leading data […]
Read more

Slaughter and May and Kirkland & Ellis top M&A legal advisers in automotive sector in 2024, reveals GlobalData

Slaughter and May and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in the automotive sector during 2024 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database has revealed that Slaughter and May […]
Read more

Mega M&A amid JPM 2025 signals potential biopharmaceutical M&A rebound, says GlobalData

The 43rd Annual JP Morgan Healthcare Conference kicked off with multi-billion-dollar mergers and acquisitions (M&A) announcements from Johnson & Johnson, Eli Lilly, and GSK. These transactions signal a return in biopharmaceutical deal-making confidence following subdued activity in 2024, with industry experts predicting larger deals in 2025 driven by regulatory changes and pipeline refueling needs, according […]
Read more

GlobalData tracks 40 years of innovation in FDA review designations

Regulatory authorities, particularly the US FDA, have played a crucial role in accelerating and incentivizing the development of innovative treatments through review designations. Since the first designation in 1984, the FDA has seen a substantial rise in the number of designations granted, reaching 694 in 2020. This surge reflects key pharmaceutical milestones, including the biotech […]
Read more
1 … 40 41 42 43 44 … 209